Hubei Huarong Holding Co.,Ltd. Stock

Equities

600421

CNE000001HY9

Construction Materials

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.1 CNY -2.87% Intraday chart for Hubei Huarong Holding Co.,Ltd. +7.39% -45.19%
Sales 2022 125M 17.28M Sales 2023 122M 16.85M Capitalization 2.18B 300M
Net income 2022 -6M -828K Net income 2023 -8M -1.1M EV / Sales 2022 17.2 x
Net Debt 2022 40.92M 5.65M Net Debt 2023 7.89M 1.09M EV / Sales 2023 17.9 x
P/E ratio 2022
-360 x
P/E ratio 2023
-278 x
Employees 225
Yield 2022 *
-
Yield 2023
-
Free-Float 41.09%
More Fundamentals * Assessed data
Dynamic Chart
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Huarong Holding to Buy Local Optical Device Maker, Marking Foray Into Sensor Industry; Shares Jump 3% MT
Hubei Huarong Holding Co.,Ltd. agreed to acquire Nanjing Kaituo Optoelectronics Technology Co., Ltd. from a group of sellers CI
Hubei Huarong Holding Co.,Ltd. announced a financing transaction CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Hubei Huarong Holding Co.,Ltd. signed the Reorganization Intention Agreement to acquire Shanghai Outdo Biotech Co., Ltd. from Shanghai Biochip Co., Ltd., Yinzhou City Construction Investment Devp Co,.Ltd, Tianjin Zhike Biotechnology Partnership (Limited Partnership) and Shanghai Qianxin Enterprise. CI
Hubei Huarong Holding Co.,Ltd. announced a financing transaction CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day-2.87%
1 week+7.39%
Current month-25.88%
1 month-26.68%
3 months-37.18%
6 months-38.07%
Current year-45.19%
More quotes
1 week
5.13
Extreme 5.13
6.37
1 month
5.13
Extreme 5.13
8.98
Current year
4.80
Extreme 4.8
11.48
1 year
4.80
Extreme 4.8
14.06
3 years
4.80
Extreme 4.8
14.85
5 years
4.80
Extreme 4.8
16.57
10 years
4.80
Extreme 4.8
30.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 42 19-01-23
Director of Finance/CFO 47 19-01-23
Director/Board Member 48 19-01-23
Members of the board TitleAgeSince
Director/Board Member 60 19-01-17
Director/Board Member 53 19-01-17
Director/Board Member 46 19-01-23
More insiders
Date Price Change Volume
24-04-26 6.1 -2.87% 3,914,100
24-04-25 6.28 +5.02% 3,971,700
24-04-24 5.98 +1.36% 3,384,000
24-04-23 5.9 +6.88% 4,954,900
24-04-22 5.52 -2.82% 4,572,300

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Hubei Huarong Holding Co Ltd, formerly Hubei Yangfan Holding Co Ltd, is a China-based company that is mainly engaged in the production and sales of molds, mold tables and various tooling shelves for precast concrete (PC) components in housing construction. The Company mainly conducts its businesses in the China market.
More about the company
  1. Stock Market
  2. Equities
  3. 600421 Stock